4-异丙基-3,5-二甲基-苯酚 | 87074-74-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-异丙基-3,5-二甲基-苯酚
• 英文名称: 3,5-dimethyl-4-isopropylphenol
• 英文别名: 4-Isopropyl-3,5-dimethyl-phenol；3,5-dimethyl-4-propan-2-ylphenol
• CAS: 87074-74-6
• 化学式: C₁₁H₁₆O
• 分子量: 164.247
• InChiKey: HTJQXVJRONQICG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2907199090

反应信息

• 作为反应物：
  描述：

  4-异丙基-3,5-二甲基-苯酚 在 四氯化碳 、 溴 作用下， 生成 2-bromo-4-isopropyl-3,5-dimethyl-phenol
  参考文献：
  名称：

  The Alkyl Derivatives of Halogen Phenols and their Bactericidal Action. II. Bromophenols

  摘要：

  DOI：

  10.1021/ja01338a057
• 作为产物：
  描述：

  3-isopropyl-2,4,6-trimethylpyrylium cation 在 sodium hydroxide 作用下， 以10%的产率得到4-异丙基-3,5-二甲基-苯酚
  参考文献：
  名称：

  A DNMR study of isomeric phenols obtained by ring-opening, ring-closure of 3-isopropyl-2,4,6-trimethylpyrylium salts: an approach to the regioselectivity of the ring-closure

  摘要：

  DOI：

  10.1016/s0040-4039(00)81898-5

文献信息

• Phosphate Ester Composition and Use
  申请人：Sasol (USA) Corporation

  公开号：US20180273556A1

  公开（公告）日：2018-09-27

  A phosphate ester composition comprising more than 50 mass % of a phosphate ester represented by Formula 1, wherein X, Y, and Z are independently selected from the group consisting of alkyl, heteroalkyl, heteroaryl or aryl, with at least one of X, Y and Z being aryl, represented by Formula 2, and wherein two or more of R3, R4 and R5 have from 1 to 10 carbon atoms, and the total number of carbon atoms in R3, R4 and R5 is from 3 to 30. The use of the phosphate ester composition as a flame retardant, a lubricant, an anti-wear additive, a hydraulic fluid, a self-extinguishing functional fluid, or an additive thereof.

  一种磷酸酯组合物，其包括质量百分比超过50%的由式子1表示的磷酸酯，其中X、Y和Z独立地选择自烷基、杂烷基、杂芳基或芳基群，其中至少有一个是芳基，由式子2表示，且R3、R4和R5中的两个或更多个具有1至10个碳原子，且R3、R4和R5中的碳原子总数为3至30。将该磷酸酯组合物用作阻燃剂、润滑剂、抗磨添加剂、液压油、自熄功能液体或其添加剂。
• PIPERIDINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS
  申请人：Baroudy Bahige M.

  公开号：US20080188485A1

  公开（公告）日：2008-08-07

  The use of CCR 5 antagonists of the formula or a pharmaceutically acceptable salt thereof, wherein R is optionally substituted phenyl, pyridyl, thiophenyl or naphthyl; R 1 is hydrogen or alkyl; R 2 is substituted phenyl, substituted heteroaryl, naphthyl fluorenyl, diphenylmethyl or optionally substituted phenyl- or heteroarylalkyl; R 3 is hydrogen, alkyl, alkoxyalkyl, cycloalkyl, cycloalkylalkyl, or optionally substituted phenyl, phenylalkyl, naphthyl, naphthylalkyl, heteroaryl or heteroarylalkyl; R 4 , R 5 and R 7 are hydrogen or alkyl; R 6 is hydrogen, alkyl or alkenyl; for the treatment of HIV, solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis is disclosed, as well as novel compounds, pharmaceutical compositions comprising them, and the combination of CCR5 antagonists of the invention in combination with antiviral agents useful in the treatment of HIV or agents useful in the treatment of inflammatory diseases.

  本发明涉及CCR5拮抗剂的使用，其化学式为或其药学上可接受的盐，其中R是可选的取代苯基、吡啶基、噻吩基或萘基；R1是氢或烷基；R2是取代苯基、取代杂环芳基、萘基、芴基、二苯甲基或可选取代的苯基或杂环芳基烷基；R3是氢、烷基、烷氧基烷基、环烷基、环烷基烷基或可选取代的苯基、苯基烷基、萘基、萘基烷基、杂环芳基或杂环芳基烷基；R4、R5和R7是氢或烷基；R6是氢、烷基或烯基；用于治疗HIV、固体器官移植排斥、移植物抗宿主病、关节炎、类风湿性关节炎、炎症性肠病、特应性皮炎、牛皮癣、哮喘、过敏或多发性硬化症，以及新型化合物、包含它们的药物组合物，以及本发明的CCR5拮抗剂与用于治疗HIV或治疗炎症性疾病的抗病毒药物的组合。
• Azepine inhibitors of Janus kinases
  申请人：Arvanitis G. Argyrios

  公开号：US20070149506A1

  公开（公告）日：2007-06-28

  The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

  本发明提供了可调节Janus激酶活性并且在治疗与Janus激酶活性相关的疾病方面有用的化合物，包括但不限于免疫相关疾病、皮肤疾病、髓细胞增生性疾病、癌症和其他疾病。
• AZEPINE INHIBITORS OF JANUS KINASES
  申请人：Arvanitis Argyrios G.

  公开号：US20120329782A1

  公开（公告）日：2012-12-27

  The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

  本发明提供了一种可以调节Janus激酶活性的化合物，这些化合物在治疗与Janus激酶活性相关的疾病方面非常有用，例如免疫相关疾病、皮肤疾病、髓系增生性疾病、癌症和其他疾病。
• RESORCINOL COMPOUNDS FOR DERMATOLOGICAL USE
  申请人：Conopco, Inc., d/b/a UNILEVER

  公开号：US20160000669A1

  公开（公告）日：2016-01-07

  Provided herein are methods and compositions comprising resorcinol derivatives for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible discontinuities of the skin resulting from skin pigmentation, skin aging, or other disorders are also disclosed.

  本文提供了使用间苯二酚衍生物治疗、调节或预防以氧化应激或退化过程为特征的皮肤状况的方法和组合物。还揭示了预防、淡化或减少由皮肤色素沉着、皮肤老化或其他疾病引起的皮肤可见不连续性的方法。